Summary
Signal counts
Assets tracked: 1
Watchlist assets: 1
Registry stop assets: 0
Sponsor overview
Innovent Biologics (Suzhou) Co. .
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT05991349
Assets
Linked programs
- IBI129: Results Not Found Signal (2/5)